Kang A, Smyth B, Neuen BL, Heerspink HJL, et al. The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double Diabetes Obes Metab 2023 May 10. doi: 10.1111/dom.15091.
PMID: 37161691